Duration of treatment among patients prescribed afatinib or erlotinib as first-line therapy for EGFR mutation-positive non-small-cell lung cancer in the USA

Jonathan Lim; Carl Samuelsen; Amanda Golembesky; Sulena Shrestha; Li Wang; Ingolf Griebsch

doi:10.2217/fon-2019-0052

Duration of treatment among patients prescribed afatinib or erlotinib as first-line therapy for EGFR mutation-positive non-small-cell lung cancer in the USA

Future Oncology ◽

10.2217/fon-2019-0052 ◽

2019 ◽

Vol 15 (13) ◽

pp. 1493-1504 ◽

Cited By ~ 1

Author(s):

Jonathan Lim ◽

Carl Samuelsen ◽

Amanda Golembesky ◽

Sulena Shrestha ◽

Li Wang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Duration Of Treatment ◽

First Line Therapy ◽

Line Therapy ◽

The Usa

Download Full-text

First-line therapy for advanced non-small cell lung cancer with activating EGFR mutation: is combined EGFR-TKIs and chemotherapy a better choice?

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-017-3516-1 ◽

2018 ◽

Vol 81 (3) ◽

pp. 443-453 ◽

Cited By ~ 4

Author(s):

Shuyun Wang ◽

Aiqin Gao ◽

Jie Liu ◽

Yuping Sun

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Activating Egfr Mutation ◽

Egfr Tkis

Download Full-text

First-line therapy of advanced non-small cell lung cancer not harboring an activating EGFR mutation

Lung Cancer Therapy Annual 7 ◽

10.3109/9781841848679.006 ◽

2012 ◽

pp. 59-74

Author(s):

Cesare Gridelli ◽

Antonio Rossi

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Activating Egfr Mutation

Download Full-text

Gefitinib as first line therapy in Malaysian patients with EGFR mutation-positive non-small-cell lung cancer: A single-center retrospective study

Oncology Letters ◽

10.3892/ol.2016.4322 ◽

2016 ◽

Vol 11 (4) ◽

pp. 2757-2762 ◽

Cited By ~ 1

Author(s):

MATIN MELLOR ABDULLAH ◽

AMIT BHAT ◽

AHMAD KAMAL MOHAMED ◽

FOO YOKE CHING ◽

NIDA AHMED ◽

...

Keyword(s):

Lung Cancer ◽

Retrospective Study ◽

Small Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell ◽

Single Center ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy

Download Full-text

First-line therapy of advanced non-small cell lung cancer not harboring an activating EGFR mutation

Lung Cancer Therapy Annual 7 ◽

10.3109/9781841848679-8 ◽

2012 ◽

pp. 67-82

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Activating Egfr Mutation

Download Full-text

Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea

Translational Lung Cancer Research ◽

10.21037/tlcr-21-501 ◽

2021 ◽

Vol 0 (0) ◽

pp. 0-0

Author(s):

Sung Yong Lee ◽

Chang-Min Choi ◽

Yoon Soo Chang ◽

Kye Young Lee ◽

Seung Joon Kim ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Real World ◽

Egfr Mutation ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy

Download Full-text

Budget Impact Analysis of Erlotib as the First-Line Therapy of Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer in Vietnam

Value in Health ◽

10.1016/j.jval.2016.03.1550 ◽

2016 ◽

Vol 19 (3) ◽

pp. A142-A143

Author(s):

TT Tran ◽

T Nguyen

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Impact Analysis ◽

Budget Impact ◽

Egfr Mutation ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy

Download Full-text

Faculty Opinions recommendation of Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717964584.793468557 ◽

2013 ◽

Author(s):

Bruno Andreoni ◽

Gianmarco Contino

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Safety And Efficacy ◽

First Line Therapy ◽

Line Therapy

Download Full-text

112P Atezolizumab as first-line therapy for patients with advanced non-small cell lung cancer: A systematic review and meta-analysis on overall survival

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(21)01954-7 ◽

2021 ◽

Vol 16 (4) ◽

pp. S759

Author(s):

E. Marcella ◽

B. Susanto ◽

S. Chen ◽

J. Tandiono ◽

A. Tancherla ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Overall Survival ◽

Small Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy

Download Full-text

A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer

British Journal of Cancer ◽

10.1038/bjc.2012.555 ◽

2013 ◽

Vol 108 (2) ◽

pp. 265-270 ◽

Cited By ~ 22

Author(s):

A Atmaca ◽

S-E Al-Batran ◽

D Werner ◽

C Pauligk ◽

T Güner ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Multicentre Phase ◽

First Line Therapy ◽

Line Therapy

Download Full-text

Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily Practice

Journal of Cancer ◽

10.7150/jca.15180 ◽

2016 ◽

Vol 7 (11) ◽

pp. 1515-1523 ◽

Cited By ~ 3

Author(s):

Yi-Hsin Liang ◽

Yu-Yun Shao ◽

Bin-Chi Liao ◽

Ho-Sheng Lee ◽

James Chih-Hsin Yang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Daily Practice ◽

Cytotoxic Chemotherapy ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy

Download Full-text